BOLT vs KR · rev $7.7M vs P/E 19, rev $147.12B
Bolt Biotherapeutics (BOLT) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Kroger Company (KR) is a grocery stores company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
BOLT currently screens at market cap $11.3M. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Not investment advice. Open the BOLT and KR stock pages for the full models.
Not investment advice.